{"sourcedb":"DevicePMAs@therightstef","sourceid":"P100028_S000","text":"Approval for the formula balloon- expandable renal stent system.  This device is indicated for use in patients with atherosclerotic disease of the renal arteries following sub-optimal percutaneous transluminal renal angioplasty (ptra) of a de novo or restenotic lesion (\u003C= 18 mm in length) located within 10 mm of the renal ostium and with a reference vessel diameter of 4.0 - 7.0 mm.  Supoptimal ptra is defined as \u003E= 50% residual stenosis, \u003E= 20 mmhg systolic or \u003E= 10 mmhg mean translesional pressure gradient, or flow-limiting dissection.","project":"consensus_PMA_Age_Indications"}